Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated May 16, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2022. Go to the latest filing (Q3 2026)

24.6B USDQ1 2022
Total value of stock positions
24.6B USD
Positions
90
Share of the ten largest
40.2%

The ten largest positions Q1 2022

  1. T-Mobile US 7.0%▲ +2.1%
  2. Amazon 5.6%▲ +52.0%
  3. GE Aerospace 4.8%▼ −29.0%
  4. Microsoft 4.2%▲ +13.2%
  5. Brookfield Asset Mgmt Inc 3.7%▼ −7.4%
  6. Parker Hannifin 3.6%▲ +3.5%
  7. Fortive 3.0%▲ +41.8%
  8. Api Group Corp 2.9%▲ +0.4%
  9. Chubb Limited 2.8%▼ −13.3%
  10. Comcast 2.7%▼ −0.9%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q1 2022

Positions Q1 2022 per 13F filing, 90 of 90
Symbol Weight Shares Reported value Change Held since
TMUS T-Mobile US 7.0% 13,418,175 1.7B USD +2.1% increased Q1 2020 9 quarters
AMZN Amazon 5.6% 422,853 1.4B USD +52.0% increased Q2 2015 28 quarters
GE GE Aerospace 4.8% 12,808,478 1.2B USD −29.0% reduced Q4 2020 6 quarters
MSFT Microsoft 4.2% 3,319,116 1.0B USD +13.2% increased Q2 2016 24 quarters
Brookfield Asset Mgmt Inc 3.7% 16,304,989 922.4M USD −7.4% reduced Q2 2021 4 quarters
PH Parker Hannifin 3.6% 3,165,334 898.2M USD +3.5% increased Q2 2020 8 quarters
FTV Fortive 3.0% 12,033,157 733.2M USD +41.8% increased Q3 2019 11 quarters
Api Group Corp 2.9% 33,463,200 703.7M USD +0.4% increased Q2 2020 8 quarters
CB Chubb Limited 2.8% 3,201,215 684.7M USD −13.3% reduced Q1 2020 9 quarters
CMCSA Comcast 2.7% 14,078,668 659.2M USD −0.9% reduced Q3 2021 3 quarters
CNC Centene Corporation 2.7% 7,806,040 657.2M USD −9.4% reduced Q2 2018 16 quarters
MA Mastercard 2.6% 1,793,488 641.0M USD new Q1 2022 1 quarter
V Visa Inc. 2.3% 2,597,820 576.1M USD −34.6% reduced Q3 2016 23 quarters
BSX Boston Scientific 2.3% 12,839,142 568.6M USD −32.3% reduced Q3 2018 15 quarters
WDAY Workday, Inc. 2.2% 2,253,470 539.6M USD +28.7% increased Q4 2021 2 quarters
AON Aon plc 2.1% 1,593,080 518.8M USD +5.5% increased Q4 2021 2 quarters
IFF International Flavors & Fragrances 2.0% 3,797,230 498.7M USD +643.1% increased Q4 2021 2 quarters
Roivant Sciences Ltd 1.8% 88,238,700 435.9M USD unchanged Q4 2021 2 quarters
Hdfc Bank Ltd 1.8% 7,073,317 433.8M USD +45.8% increased Q3 2021 3 quarters
Royalty Pharma PLC 1.7% 10,764,472 419.4M USD +4.4% increased Q2 2020 8 quarters
Adaptive Biotechnologies Cor 1.7% 29,993,708 416.3M USD unchanged Q2 2019 12 quarters
Guardant Health Inc 1.6% 5,812,234 385.0M USD +14.5% increased Q3 2019 11 quarters
MRSH Marsh McLennan 1.6% 2,250,643 383.6M USD +78.4% increased Q4 2020 6 quarters
UBER Uber 1.5% 10,437,199 372.4M USD −1.4% reduced Q3 2021 3 quarters
Match Group Inc New 1.2% 2,744,468 298.4M USD +44.5% increased Q4 2020 6 quarters
Biomarin Pharmaceutical Inc 1.2% 3,752,393 289.3M USD +30.7% increased Q4 2021 2 quarters
TMO Thermo Fisher Scientific 1.2% 484,696 286.3M USD +129.7% increased Q2 2020 8 quarters
Xp Inc 1.2% 9,443,312 284.2M USD new Q1 2022 1 quarter
AMP Ameriprise Financial 1.1% 923,328 277.3M USD −36.5% reduced Q1 2021 5 quarters
OTIS Otis Worldwide 1.1% 3,538,164 272.3M USD new Q1 2022 1 quarter
Bridgebio Pharma Inc 1.1% 26,620,991 270.2M USD unchanged Q2 2019 12 quarters
META Meta Platforms 1.1% 1,209,602 269.0M USD −35.9% reduced Q4 2020 6 quarters
NOW ServiceNow 1.0% 440,450 245.3M USD +96.4% increased Q4 2020 6 quarters
Catalent Inc 0.9% 1,893,644 210.0M USD +66.2% increased Q1 2018 17 quarters
Ginkgo Bioworks Holdings Inc 0.8% 51,055,144 205.8M USD −84.9% reduced Q3 2021 3 quarters
Tenet Healthcare Corp 0.8% 2,233,647 192.0M USD −30.4% reduced Q1 2021 5 quarters
Laboratory Corp Amer HLDGS 0.8% 727,287 191.8M USD −14.5% reduced Q3 2020 7 quarters
Intellia Therapeutics Inc 0.7% 2,468,760 179.4M USD +56.3% increased Q2 2021 4 quarters
Global E Online Ltd 0.7% 5,128,448 173.2M USD +1.8% increased Q4 2021 2 quarters
DE Deere & Company 0.7% 403,163 167.5M USD −56.8% reduced Q1 2021 5 quarters
BEKE KE Holdings 0.7% 13,440,125 166.3M USD +360.2% increased Q4 2021 2 quarters
RIVN Rivian Automotive 0.7% 3,204,389 161.0M USD unchanged Q4 2021 2 quarters
Zoominfo Technologies Inc 0.6% 2,644,137 158.0M USD −2.3% reduced Q2 2021 4 quarters
LI Li Auto 0.6% 6,000,478 154.9M USD +33.8% increased Q4 2021 2 quarters
SHOP Shopify 0.6% 223,721 151.2M USD new Q1 2022 1 quarter
CRL Charles River Laboratories 0.6% 521,653 148.1M USD +33.7% increased Q1 2021 5 quarters
PODD Insulet Corporation 0.6% 547,387 145.8M USD −19.3% reduced Q3 2020 7 quarters
Acadia Healthcare Company In 0.6% 2,130,433 139.6M USD +1.9% increased Q4 2020 6 quarters
Molina Healthcare Inc 0.6% 416,883 139.1M USD −6.9% reduced Q3 2019 11 quarters
Zai Lab Ltd 0.6% 3,133,297 137.8M USD +3.8% increased Q1 2021 5 quarters
Procept Biorobotics Corp 0.5% 3,658,892 128.0M USD −25.4% reduced Q3 2021 3 quarters
BKNG Booking Holdings 0.5% 54,234 127.4M USD −57.7% reduced Q2 2021 4 quarters
Karuna Therapeutics Inc 0.5% 974,345 123.5M USD +12.8% increased Q3 2020 7 quarters
PGR Progressive Corporation 0.5% 1,037,306 118.2M USD new Q1 2022 1 quarter
Inhibrx Inc 0.5% 5,305,866 118.2M USD unchanged Q3 2020 7 quarters
Pvh Corporation 0.5% 1,542,375 118.2M USD +100.6% increased Q2 2020 8 quarters
Avantor Inc 0.5% 3,459,963 117.0M USD −60.6% reduced Q2 2019 12 quarters
Biohaven Pharmactl Hldg Co L 0.5% 966,139 114.6M USD +177.0% increased Q4 2021 2 quarters
JD JD.com (ADR) 0.4% 1,748,330 101.2M USD −53.6% reduced Q2 2021 4 quarters
Perrigo Co PLC 0.4% 2,525,266 97.0M USD new Q1 2022 1 quarter
MET MetLife 0.4% 1,362,166 95.7M USD new Q1 2022 1 quarter
Lithia Mtrs Inc 0.4% 316,904 95.1M USD −59.9% reduced Q1 2021 5 quarters
Zentalis Pharmaceuticals Inc 0.4% 2,026,656 93.5M USD −4.3% reduced Q2 2020 8 quarters
Amylyx Pharmaceuticals Inc 0.4% 7,170,536 92.1M USD new Q1 2022 1 quarter
TTWO Take-Two Interactive 0.4% 588,443 90.5M USD −51.1% reduced Q4 2021 2 quarters
DG Dollar General 0.4% 388,317 86.5M USD new Q1 2022 1 quarter
Inspire Med Sys Inc 0.3% 310,881 79.8M USD new Q1 2022 1 quarter
ELV Elevance Health 0.3% 140,895 69.2M USD new Q1 2022 1 quarter
BX Blackstone Inc. 0.3% 509,587 64.7M USD new Q1 2022 1 quarter
Celldex Therapeutics Inc New 0.3% 1,846,647 62.9M USD +143.7% increased Q3 2021 3 quarters
XYZ Block, Inc. 0.2% 451,534 61.2M USD −0.8% reduced Q4 2021 2 quarters
4D Molecular Therapeutics In 0.2% 3,937,914 59.5M USD unchanged Q4 2020 6 quarters
BA Boeing 0.2% 305,347 58.5M USD new Q1 2022 1 quarter
Pharvaris N V 0.2% 2,480,319 46.4M USD +1.0% increased Q1 2021 5 quarters
Farfetch Ltd 0.2% 2,819,222 42.6M USD −52.6% reduced Q3 2021 3 quarters
UNH UnitedHealth Group 0.2% 76,910 39.2M USD new Q1 2022 1 quarter
Orion Acquisition Corp 0.2% 3,788,774 37.2M USD +3.3% increased Q1 2021 5 quarters
Unum Group 0.1% 1,137,645 35.8M USD new Q1 2022 1 quarter
Talaris Therapeutics Inc 0.1% 3,289,617 32.4M USD unchanged Q2 2021 4 quarters
Rallybio Corp 0.1% 4,194,777 29.3M USD unchanged Q3 2021 3 quarters
Edgewise Therapeutics Inc 0.1% 2,727,249 26.5M USD unchanged Q1 2021 5 quarters
Olaplex HLDGS Inc 0.1% 1,613,189 25.2M USD unchanged Q3 2021 3 quarters
Pmv Pharmaceuticals Inc < 0.1% 1,076,000 22.4M USD −39.9% reduced Q3 2020 7 quarters
Kinnate Biopharma Inc < 0.1% 1,820,462 20.5M USD unchanged Q4 2020 6 quarters
JPM JPMorgan Chase < 0.1% 119,706 16.3M USD new Q1 2022 1 quarter
Nuvalent Inc < 0.1% 1,110,170 15.4M USD −32.6% reduced Q3 2021 3 quarters
Day One Biopharmaceuticals I < 0.1% 1,157,424 11.5M USD unchanged Q2 2021 4 quarters
Lianbio < 0.1% 1,500,000 5.6M USD unchanged Q4 2021 2 quarters
Tdcx Inc < 0.1% 141,117 1.7M USD −86.1% reduced Q4 2021 2 quarters
Vtex < 0.1% 30,371 187.0K USD −99.0% reduced Q3 2021 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 96.9M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 96.9M USD

Breakdown by sector

  • Industrials 14.9%
  • Financials 14.0%
  • Communication Services 11.1%
  • Health Care 7.8%
  • Technology 7.3%
  • Consumer Discretionary 6.8%
  • Materials 2.0%
  • Consumer Staples 0.4%
  • not in our coverage 35.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close